Recent research has revealed that when the hormone progestin is taken as a part of hormone replacement therapy (HRT) following menopause, deficits in hearing sensitivity and auditory speech processing, appeared to be exacerbated according to a research team at the Rochester School of Medicine and Dentistry in New York.
